Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-27

FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application from Apotex Corp. for a generic amlodipine/atorvastatin combination tablet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Atorvastatin (amlodipine besylate and atorvastatin calcium)

Snippet

SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)